BTG Pactual Asset Management US’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11M Buy
11,939
+2,140
+22% +$2.17M 0.95% 29
2025
Q4
$10.5M Buy
9,799
+3,765
+62% +$3.6M 1.03% 25
2025
Q3
$4.6M Buy
6,034
+3,159
+110% +$2.35M 0.22% 57
2025
Q2
$2.24M Buy
2,875
+192
+7% +$149K 0.25% 85
2025
Q1
$2.22M Buy
2,683
+556
+26% +$463K 0.24% 95
2024
Q4
$1.69M Buy
2,127
+336
+19% +$278K 0.18% 118
2024
Q3
$1.59M Buy
1,791
+432
+32% +$388K 0.14% 131
2024
Q2
$1.23M Buy
+1,359
New +$1.09M 0.18% 88

Other funds holding LLY

BTG Pactual Asset Management US's LLY Position: Q1 2026 in Review

BTG Pactual Asset Management US increased its Eli Lilly (LLY) stake by 22% in Q1 2026, buying an estimated $2.17M and bringing the position to 11,939 shares worth $11M. The position accounts for 0.95% of the portfolio, ranked #29.

BTG Pactual Asset Management US first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • BTG Pactual Asset Management US held 11,939 shares of Eli Lilly worth $11M as of Q1 2026.
  • BTG Pactual Asset Management US bought 2,140 Eli Lilly shares in Q1 2026, an estimated $2.17M.
  • Eli Lilly made up 0.95% of BTG Pactual Asset Management US's portfolio in Q1 2026, its #29 holding.
  • BTG Pactual Asset Management US first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on BTG Pactual Asset Management US's 13F filing for Q1 2026, filed 14 May 2026.